124 related articles for article (PubMed ID: 38330258)
1. Chelerythrine Chloride is an Affinity-Labeling Inactivator of CYP3A4 by Modification of Cysteine239.
Mao X; Zhao G; Wang Q; He J; Liu Y; Liu T; Li W; Peng Y; Zheng J
J Med Chem; 2024 Feb; 67(4):2802-2811. PubMed ID: 38330258
[TBL] [Abstract][Full Text] [Related]
2. Meclizine, a pregnane X receptor agonist, is a direct inhibitor and mechanism-based inactivator of human cytochrome P450 3A.
Foo WY; Tay HY; Chan EC; Lau AJ
Biochem Pharmacol; 2015 Oct; 97(3):320-30. PubMed ID: 26239802
[TBL] [Abstract][Full Text] [Related]
3. Piperine Is a Mechanism-Based Inactivator of CYP3A.
Cui T; Wang Q; Tian X; Zhang K; Peng Y; Zheng J
Drug Metab Dispos; 2020 Feb; 48(2):123-134. PubMed ID: 31748224
[TBL] [Abstract][Full Text] [Related]
4. Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4.
Guo X; Li W; Li Q; Chen Y; Zhao G; Peng Y; Zheng J
Chem Res Toxicol; 2019 Sep; 32(9):1791-1800. PubMed ID: 31414593
[TBL] [Abstract][Full Text] [Related]
5. Icotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene Intermediate.
Sun C; Zhao H; Li W; Jia Y; Yang Y; Peng Y; Zheng J
Drug Metab Dispos; 2021 Oct; 49(10):892-901. PubMed ID: 34312304
[TBL] [Abstract][Full Text] [Related]
6. Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4.
Tang LWT; Teng JW; Verma RK; Koh SK; Zhou L; Go ML; Fan H; Chan ECY
Drug Metab Dispos; 2021 Sep; 49(9):856-868. PubMed ID: 34326139
[TBL] [Abstract][Full Text] [Related]
7. Direct and Sequential Bioactivation of Pemigatinib to Reactive Iminium Ion Intermediates Culminates in Mechanism-Based Inactivation of Cytochrome P450 3A.
Tang LWT; Wei W; Verma RK; Koh SK; Zhou L; Fan H; Chan ECY
Drug Metab Dispos; 2022 May; 50(5):529-540. PubMed ID: 35153194
[TBL] [Abstract][Full Text] [Related]
8. Chelerythrine and dihydrochelerythrine induce G1 phase arrest and bimodal cell death in human leukemia HL-60 cells.
Vrba J; Dolezel P; Vicar J; Modrianský M; Ulrichová J
Toxicol In Vitro; 2008 Jun; 22(4):1008-17. PubMed ID: 18358694
[TBL] [Abstract][Full Text] [Related]
9. Modulation of multidrug resistance in cancer cells by chelidonine and Chelidonium majus alkaloids.
El-Readi MZ; Eid S; Ashour ML; Tahrani A; Wink M
Phytomedicine; 2013 Feb; 20(3-4):282-94. PubMed ID: 23238299
[TBL] [Abstract][Full Text] [Related]
10. NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition.
Kosaka M; Zhang D; Wong S; Yan Z
Drug Metab Dispos; 2020 Aug; 48(8):655-661. PubMed ID: 32482757
[TBL] [Abstract][Full Text] [Related]
11. Effect of quaternary benzo[c]phenanthridine alkaloids sanguinarine, chelerythrine and fagaronine on some mammalian cells.
Vavrecková C; Ulrichová J; Hajdúch M; Grambal F; Weigl E; Simánek V
Acta Univ Palacki Olomuc Fac Med; 1994; 138():7-10. PubMed ID: 8714083
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Screening of Six Protein Kinase Inhibitors for Time-Dependent Inhibition of CYP2C8 and CYP3A4: Possible Implications with regard to Drug-Drug Interactions.
Filppula AM; Mustonen TM; Backman JT
Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):739-748. PubMed ID: 29956478
[TBL] [Abstract][Full Text] [Related]
13. Mechanism-based inactivation of cytochrome P450 2D6 by chelidonine.
Liu Y; Cui T; Peng Y; Ji M; Zheng J
J Biochem Mol Toxicol; 2019 Feb; 33(2):e22251. PubMed ID: 30368994
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4.
Chan WK; Delucchi AB
Life Sci; 2000 Nov; 67(25):3103-12. PubMed ID: 11125847
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based inactivation of cytochrome P450 3A4 by methylenedioxyphenyl lignans from Acanthopanax chiisanensis.
Yoo HH; Lee SH; Jin C; Kim DH
Planta Med; 2008 Jun; 74(8):822-7. PubMed ID: 18563665
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib.
Teng WC; Oh JW; New LS; Wahlin MD; Nelson SD; Ho HK; Chan EC
Mol Pharmacol; 2010 Oct; 78(4):693-703. PubMed ID: 20624855
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity of O4-benzo[c]phenanthridine alkaloids against HCT-116 and HL-60 tumor cells.
Hatae N; Fujita E; Shigenobu S; Shimoyama S; Ishihara Y; Kurata Y; Choshi T; Nishiyama T; Okada C; Hibino S
Bioorg Med Chem Lett; 2015 Jul; 25(14):2749-52. PubMed ID: 26026362
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Studies of Cytochrome P450 3A4 Time-Dependent Inhibition Using Two Cysteine-Targeting Electrophiles.
Barr JT; Wang Z; Min X; Wienkers HJ; Rock BM; Rock DA; Wienkers LC
Drug Metab Dispos; 2020 Jun; 48(6):508-514. PubMed ID: 32193357
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric investigation of chelerythrine and dihydrochelerythrine biotransformation patterns in human hepatocytes.
Vacek J; Papoušková B; Kosina P; Galandáková A; Ulrichová J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():17-24. PubMed ID: 24184831
[TBL] [Abstract][Full Text] [Related]
20. The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir.
Lin HL; D'Agostino J; Kenaan C; Calinski D; Hollenberg PF
Drug Metab Dispos; 2013 Oct; 41(10):1813-24. PubMed ID: 23886699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
